PLYMOUTH, Minn.--(BUSINESS WIRE)--Interrad Medical announces the SecurAcath device is now recommended in the 2016 Infusion Therapy Standards of Practice just released by the Infusion Nurses Society ...
PLYMOUTH, Minn.--(BUSINESS WIRE)--Interrad Medical, Inc., a privately held medical device company, announces excellent results of a clinical study published in JAMA Pediatrics titled, “Securement to ...
The company identified 3 published economic studies, but the external assessment centre considered them to be outside the scope. It did not identify any further economic studies. The company presented ...
Interrad Medical has announced it has received FDA clearance for four new sizes of the SecurAcath subcutaneous catheter securement device, according to a news release ...
Interrad Medical, Inc. a privately held medical device company, announced today that it has raised approximately $10 million in its Series C financing. The funding was raised through a private ...
Plymouth, MN-based Interrad Medical has raised approximately $10 million in Series C financing through a private placement by RBC Wealth Management Group. The financing will be used to support the ...
FERNDALE, Mich. -- A new study on securement for central vascular access devices (CVAD) suggests that subcutaneous anchor securement systems (SASS) are shown to be more effective at keeping central ...
The largest study of patients with peripherally inserted central catheters (PICC) utilizing a subcutaneous anchoring securement system (SASS) ever conducted shows that using subcutaneous anchors to ...
Each year, health care professionals worldwide insert 500 million vascular access catheters into patients’ veins for blood draws or intravenous medications. Traditionally, catheters are attached to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results